Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes

Diabetes Care

Volumn 22, Issue 2, 1999, Pages 288-293

  Kelly, Irene E ^a   Han, Thang S ^a   Walsh, Kevin ^a   Lean, Michael E J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; TROGLITAZONE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; LIPID STORAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; BODY WEIGHT; CALIBRATION; CHROMANS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLACEBOS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0032934104     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.2.288     Document Type: Article

References (20)

1. Ghazzi MN, Perez JE, Antonucci TK, Driscoll JH, Huang SM, Faja BW, Whitcomb RW: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes 46:433-439, 1997
2. Fujiwara T, Yoshioka S, Yoshioka T, Ushiama I, Horikoshi H: Characterization of a new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
3. Petrie JR, Donnelly R: New pharmacological approaches to insulin and lipid metabolism. Drugs 47:701-710, 1994
4. Satiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669, 1996
5. WHO Expert Committee on Physical Status: The Use and Interpretation of Anthropometry: Report of a WHO Expert Committee. Geneva, World Health Org., 1995 (Tech. Rep. ser.)
6. Lean MEJ, Han TS, Deurenberg P: Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr 63:4-14, 1996
7. Han TS, McNeill G, Seidell JC, Lean MEJ: Predicting intra-abdominal fatness from anthropometric measures: the influence of stature. Int J Obes 21:587-593, 1997
8. Garrow JS: Energy and Obesity in Man. New York, Elsevier, 1974
9. Siri WE: Body composition from fluid spaces and density analysis of methods. In Techniques for Measuring Body Composition. Brozeck J, Henschel A, Eds. Washington, DC, National Academy of Sciences/National Research Council. 1961, p. 223-244
10. Han TS, Kelly IE, Walsh K, Greene RME, Lean MEJ: Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes 21:1161-1166, 1997
11. Björntorp P: Metabolic implication of body fat distribution. Diabetes Care 12:1132-1143, 1991
12. Lemieux S, Prud'homme D, Nadeau A, Tremblay A, Bouchard C. Després J-P: Seven year changes in body fat and visceral adipose tissue in women: associations with indexes of plasma glucose-insulin homeostasis. Diabetes Care 19:983-991, 1996
13. Antonucci T, McLain R, Whitcomb R, Lockwood D: Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care 20: 188-193, 1997
14. Oates JA, Wood AJJ, Gerich JE: Medical intelligence: drug therapy: oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
15. Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI: The metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus: a randomized, double-blind, placebo controlled trial. Ann Intern Med 123:176-185, 1998
16. Lefebvre A, Laville M, Vega N, Riou J, Van Gall L, Auwerx J, Vidal H: Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47:98-103, 1998
17. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activator of peroxisome proliferator-activated receptor gamma have depot specific effects on human preadipocyte differentiation. J Clin Invest 100:3149-3153, 1997
18. Lean MEJ: Brown adipose tissue in humans. Proc Nutr Soc 48:243-256, 1989
19. Mercer SW, Trayhurn P: Effects of ciglitazone on insulin resistance and thermogenic responsiveness to acute cold in brown adipose tissue of genetically obese (ob/ob) mice. FEBS Lett 195:12-16, 1986
20. Gilbert RE, Cooper ME. Krum H: Drug administration in patients with diabetes mellitus. Drug Safety 18:441-455, 1998